Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
3:01 pm
Sale
13GSierra Oncology, Inc.
SRRA
Rock Springs Capital Management LP0
0%
-1,184,793decrease
(Position Closed)
View
2023-02-10
4:20 pm
Sale
13GSierra Oncology, Inc.
SRRA
Versor Investments LP0
0%
-1,266,927decrease
(Position Closed)
View
2022-07-11
4:30 pm
Sale
13DSierra Oncology, Inc.
SRRA
Abingworth LLP0
0%
-2,193,626decrease
(Position Closed)
View
2022-07-05
5:06 pm
Sale
13GSierra Oncology, Inc.
SRRA
Vivo Capital IX LLC0
0%
-2,735,852decrease
(Position Closed)
View
2022-05-06
4:33 pm
Sale
13DSierra Oncology, Inc.
SRRA
Longitude Capital Partners III LLC1,485,140
5.7%
-2,140,130decrease
(-59.03%)
View
2022-04-22
2:32 pm
Purchase
13GSierra Oncology, Inc.
SRRA
Versor Investments LP1,266,927
5.3%
1,266,927increase
(New Position)
View
2022-03-29
4:23 pm
Purchase
13GSierra Oncology, Inc.
SRRA
Frazier Life Sciences Public Fund L.P.2,366,853
10%
1,562,186increase
(+194.14%)
View
2022-03-21
4:52 pm
Unchanged
13DSierra Oncology, Inc.
SRRA
Abingworth LLP2,193,626
8.9%
0
(Unchanged)
View
2022-03-15
4:30 pm
Unchanged
13DSierra Oncology, Inc.
SRRA
ORBIMED ADVISORS LLC3,044,753
12.2%
0
(Unchanged)
View
2022-02-14
6:25 pm
Purchase
13GSierra Oncology, Inc.
SRRA
Rock Springs Capital Management LP1,184,793
7.87%
617,435increase
(+108.83%)
View
2022-02-14
4:21 pm
Sale
13GSierra Oncology, Inc.
SRRA
Venrock Healthcare Capital Partners II L.P.984,746
6.1%
-7,304,732decrease
(-88.12%)
View
2022-02-14
3:57 pm
Sale
13GSierra Oncology, Inc.
SRRA
CAXTON CORP1,119,322
7%
-23,039decrease
(-2.02%)
View
2022-02-11
5:22 pm
Purchase
13GSierra Oncology, Inc.
SRRA
Vivo Capital IX LLC2,735,852
14.7%
799,999increase
(+41.33%)
View
2022-02-11
4:57 pm
Unchanged
13GSierra Oncology, Inc.
SRRA
New Leaf Biopharma Opportunities I L.P.787,414
4.1%
0
(Unchanged)
View
2022-02-10
5:00 pm
Purchase
13DSierra Oncology, Inc.
SRRA
Abingworth LLP2,193,626
11.3%
150,000increase
(+7.34%)
View
2022-02-10
4:55 pm
Purchase
13GSierra Oncology, Inc.
SRRA
GILEAD SCIENCES INC.
GILD
1,450,566
9.2%
377,266increase
(+35.15%)
View
2022-02-10
10:54 am
Purchase
13GSierra Oncology, Inc.
SRRA
ADAGE CAPITAL PARTNERS GP L.L.C.1,230,468
8.17%
436,328increase
(+54.94%)
View
2022-02-07
5:12 pm
Purchase
13GSierra Oncology, Inc.
SRRA
PFM Health Sciences LP1,062,888
5.5%
1,062,888increase
(New Position)
View
2022-02-04
5:22 pm
Purchase
13DSierra Oncology, Inc.
SRRA
Longitude Capital Partners III LLC3,625,270
17.4%
175,000increase
(+5.07%)
View
2022-02-02
4:33 pm
Unchanged
13DSierra Oncology, Inc.
SRRA
ORBIMED ADVISORS LLC3,044,753
15.3%
0
(Unchanged)
View
Goto 0, 1, 2, Next